Federal Circuit Clarifies Reach Of : vimarsana.com

Litigators in the life sciences field are no doubt familiar with the so-called "artificial" act of infringement established by 35 U.S.C. § 271(e)(2)(A)-(B): namely, that a party...

Related Keywords

Delaware , United States , , Lupin Ltd , Abbreviated New Drug Application , Biologics License Application , Federal Circuit , Treatment Patents , Mondaq , Federal Circuit Clarifies Reach Of Quot Artificial Act Patent Infringement , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , Intellectual Property , Patent ,